| Application no. and date | 14852834.2 (espacenet) (Federated) (European Patent Register), 20141008 | | Patent/reg. no. and date | DK/EP 3055332, 20190925 | | Publication date | 20160817 | | Priority no. and date | US 201361888337 P, 20131008, US 201361888365 P, 20131008, US 201461948363 P, 20140305, US 201462004815 P, 20140529 | | EP pub. no. and date |
EP 3055332 20160817 | | Effective date | | | Applicant/owner | ImmunoGen, Inc., 830 Winter Street
Waltham, MA 02451-1477, US | | Applicant ref. no. | P70122DK01 | | Inventor | LUTZ, Robert J., 218 Old Connecticut Path
Wayland, Massachusetts 01778, US,
PONTE, Jose, 83 Cottage Lane
Weymouth, Massachusetts 02188, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) | | Title | ANTI-FOLR1-IMMUNKONJUGAT-DOSERINGSREGIMER | | Int. application no. | US2014059716 | | Int. publication no. | WO2015054400 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
